To ensure your compliance strategy lines up with these timelines, read our comprehensive guide to conducting an EU MDR Gap Analysis.
Fast-track EUDAMED actor registration, SRN issuance, and MDR gap checks for US, UK, and non-EU manufacturers. Response within 24 hours.
EU MDR deadlines have been extended three times since the regulation came into force. Many manufacturers assume another extension is coming. It is not. The European Commission confirmed in 2024 that the current timeline is final. This guide gives you every confirmed date, what it means for your device class, and what you must do now. To avoid critical compliance failures under the new timeline framework, companies must undergo an immediate MDR gap assessment.
Manufacturers must finalize Notified Body lodging to maintain validity under transitional extensions.
Mandatory registration for Actor Modules (MDR/IVDR) to maintain clear supply chains.
Final transition end-date for specific Annex XVI and Class I legacy systems.
EUDAMED enforcement is 13 days away. Notified Bodies are currently reporting 12–18 month backlogs for technical file reviews — Class IIa, IIb and III manufacturers who have not yet submitted to a Notified Body are at serious risk of missing the 2027–2028 deadlines. Class I manufacturers and all economic operators (importers, distributors, EU ARs) must complete EUDAMED registration before 28 May 2026 or face immediate market suspension.
📥 Download 2026 Compliance Checklist (Free PDF)
| Deadline | Date | Who it affects | Status |
|---|---|---|---|
| EUDAMED mandatory | 28 May 2026 | All manufacturers, EU ARs, importers, distributors | 25 days away |
| Class III & IIb implantables — MDR certification required | 31 Dec 2027 | High-risk and implantable devices | 19 months |
| Class IIb (non-implantable) — MDR certification required | 31 Dec 2028 | Class IIb non-implantables | 31 months |
| Class IIa — MDR certification required | 31 Dec 2028 | Medium-risk devices | 31 months |
| Class I sterile & measuring — MDR certification required | 31 Dec 2028 | Class I with special requirements | 31 months |
| Class I (non-sterile, non-measuring) — self-declared | No NB required | Lowest-risk devices | Technical file required |
28 May 2026 is no longer theoretical. EUDAMED (the European Database on Medical Devices) becomes mandatory for every entity in the EU medical device supply chain. This is the most immediate deadline and applies to every manufacturer regardless of device class.
After this date, any manufacturer, EU Authorized Representative, importer or distributor without a valid SRN (Single Registration Number) cannot legally place devices on the EU market. Competent Authorities in each member state will act immediately — no warning letters, no grace period.
What you need before 28 May 2026:
Class I devices do not require a Notified Body for CE marking — but this does not mean there is nothing to do. You still need:
Class IIa devices require a Notified Body audit. With average EU MDR review times of 13–18 months, and a December 2028 final deadline, you should be submitting your technical file to a Notified Body no later than mid-2027. Realistically, if you want to avoid a rushed submission, you should begin your NB application now.
The deadline for Class IIb implantable devices is 31 December 2027 — 19 months from now. With a 13–18 month Notified Body review, you have almost no buffer remaining. Your technical file must be submission-ready within weeks, not months.
Class III devices (highest risk) also face the December 2027 deadline. Some Notified Bodies are reporting review times of up to 24 months. If you have not already engaged a Notified Body and submitted your application, you are behind schedule.
There are currently 24 Notified Bodies designated under EU MDR — significantly fewer than the 58 that existed under the old MDD system. Audit slots are limited. Several major NBs are reporting full calendars into 2026 and beyond.
Manufacturers who wait until mid-2026 to begin their NB process for Class III or IIb implantable devices will almost certainly miss the December 2027 deadline and face market suspension.
Missing the EUDAMED deadline (28 May 2026) results in immediate market suspension. Devices are removed from sale until registration is complete. There is no warning process and no appeals period during which you can continue trading.
Missing the Notified Body certification deadlines (2027–2028) by class results in the CE mark being void. Devices cannot be placed on the market or transferred further in the supply chain until valid MDR certification is in place.
Book a free 20-minute call. NordMDR AB will identify your device class, confirm which deadlines apply, and tell you exactly what you need to do — and in what order. Fixed fees, 5-day onboarding, Stockholm-based.
Book a Free 15-Min Strategy Call →